{"id":1018650,"date":"2026-11-09T07:36:01","date_gmt":"2026-11-09T12:36:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/"},"modified":"2026-11-09T07:36:01","modified_gmt":"2026-11-09T12:36:01","slug":"novabridge-biosciences-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"NovaBridge Biosciences to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ROCKVILLE, Md., Nov.  09, 2026  (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (\u201cNovaBridge\u201d or the \u201cCompany\u201d) (Nasdaq: NBP) today announced that members of its leadership team will participate in two upcoming investor conferences. At Jefferies, Chief Executive Officer Srishti Gupta will present with Jeffrey Nau, President and Chief Executive Officer of Visara, NovaBridge\u2019s majority-owned ophthalmology company focused on advancing a portfolio of differentiated therapies for ocular diseases. At Evercore, Dr. Gupta will be joined by NovaBridge Chief Financial Officer Chuck Silberstein.<\/p>\n<p>Conference details:<\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference in London<\/strong><br \/>\n        <br \/>Format: Presentation and one-on-one meetings<br \/>Presenters: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge and Jeffrey Nau, PhD, MMS, President and Chief Executive Officer, Visara<br \/>Date: Monday, November 16, 2026<br \/>Time: 5:30 AM ET \/ 10:30 AM GMT<br \/>Webcast Registration Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VFtmF8SJmZrtBniIqgeZUN0iEvfG-g7YHsussKuVx1JvrbiqGHCR_h3RVc34u0cZRneoPSSd7ldmCgHJSsO51fD5l5T2hY2h6bnnJWzZ-N3omd-xGpkjahN4vf0Ka9ovvJcfdEaP55kybdUzuIajeA==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>\n        <strong>9th Annual Evercore Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat and one-on-one meetings<br \/>Presenters: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge and Chuck Silberstein, MD, MBA, Chief Financial Officer, NovaBridge<br \/>Date: Monday, November 30, 2026<br \/>Time: 12:55 PM ET<br \/>Webcast Registration Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VFtmF8SJmZrtBniIqgeZUKoKBiV1TObTD10qh2igSqceEAMPpAFXcoBpaHYy3DWwcf9OLC_2DdUbfsehbh3GMg_0RWwjBiGqFrSmOVflWMInOaqD8IwrCema1RAmMoE2EKPJzuE3TJ104_dKal7O7A==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>Webcasts of the presentations will be accessible in the News &amp; Events page of the\u00a0NovaBridge\u00a0website for 90 days.<\/p>\n<p>\n        <strong>About NovaBridge Biosciences<\/strong><br \/>\n        <br \/>NovaBridge Biosciences (&#8220;NovaBridge&#8221;) (NASDAQ: NBP) is a global biotechnology company focused on identifying, developing and maximizing the value of differentiated therapeutic assets. The Company advances programs through clinical development and pursues the financing and partnering strategies best suited to each opportunity.<\/p>\n<p>NovaBridge&#8217;s portfolio is led by givastomig, a Claudin 18.2 \u00d7 4-1BB bispecific antibody being developed for the potential treatment of gastrointestinal malignancies, and Visara, its majority-owned ophthalmology subsidiary. Through Visara, NovaBridge is building a diversified ophthalmology franchise designed to address unmet needs across diseases of the front and back of the eye.<\/p>\n<p>NovaBridge&#8217;s objective is to build a sustainable biotechnology company by repeatedly identifying differentiated innovation, advancing it efficiently, and bringing novel therapies to patients through the path best suited to each opportunity.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=syGAg2cmfD2cBiWIqXV-ucX5Zi2QsFcf4nh8QOmb-KXf9bq_XQQC7FTd1xGloO9SS0hhkaGTJaRo5UoLDiwgkVZh-wQS5c6rspXM8qM1WgA=\" rel=\"nofollow\" target=\"_blank\">www.novabridge.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F3c5urGl5KMXfjqkQ-XwASdrAehAFSqWuCcVfHIDF6xrzGfEHXJO-b4-KCCUfWq3V-8jbmQsfbUaer3z2AP6TWGjsKHXYsLPQG-rxydfrnw5Ytr9kUFUfOXmk7SmFbgil09B_vrOJI8hefCHQd4D1w==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>NovaBridge Investor &amp; Media Contacts<\/strong>\n      <\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Bill Begien, SVP, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xUnZ7OmC3_FDJumHKkjYKYYy7e_dyuohYDwFR2gH80TwBb0fI-T-xP5XfoZQZ8sUZTZWiXtHaPX3gQHexOftDC-XW_YgJPut4tcqQZP8vkNQNKL0SlHNUY6tQSSR3Xwc\" rel=\"nofollow\" target=\"_blank\">bill.begien@novabridge.com<\/a><br \/>IR@novabridge.com<\/p>\n<p>\n        <strong>Media Inquiries:<\/strong><br \/>\n        <br \/>Eric Van Zanten, VP, Communications<br \/>+1-610-529-6219<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iPa2uHMWV-fBqxrnFcJUDYvFoseZDDViczpYkwTGODYtAGRvU9mHwwcoTEGuysr2AOg9Ql8felW2Ga9PflW3-ZfPg5ArGuO9GE_LSMAbUfsWQakw1HGwVo4yprzjeaxw\" rel=\"nofollow\" target=\"_blank\">eric.vanzanten@novabridge.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWEzODlhNjQtMWVkZi00ZjFiLTg3M2EtNDhiZjM1MmQxMjJlLTUwMDEyNTAyOS0yMDI2LTExLTA5LWVu\/tiny\/NovaBridge-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (\u201cNovaBridge\u201d or the \u201cCompany\u201d) (Nasdaq: NBP) today announced that members of its leadership team will participate in two upcoming investor conferences. At Jefferies, Chief Executive Officer Srishti Gupta will present with Jeffrey Nau, President and Chief Executive Officer of Visara, NovaBridge\u2019s majority-owned ophthalmology company focused on advancing a portfolio of differentiated therapies for ocular diseases. At Evercore, Dr. Gupta will be joined by NovaBridge Chief Financial Officer Chuck Silberstein. Conference details: Jefferies Global Healthcare Conference in London Format: Presentation and one-on-one meetingsPresenters: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge and Jeffrey Nau, PhD, MMS, President and Chief Executive Officer, VisaraDate: Monday, November 16, 2026Time: 5:30 AM ET \/ 10:30 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NovaBridge Biosciences to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1018650","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NovaBridge Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NovaBridge Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (\u201cNovaBridge\u201d or the \u201cCompany\u201d) (Nasdaq: NBP) today announced that members of its leadership team will participate in two upcoming investor conferences. At Jefferies, Chief Executive Officer Srishti Gupta will present with Jeffrey Nau, President and Chief Executive Officer of Visara, NovaBridge\u2019s majority-owned ophthalmology company focused on advancing a portfolio of differentiated therapies for ocular diseases. At Evercore, Dr. Gupta will be joined by NovaBridge Chief Financial Officer Chuck Silberstein. Conference details: Jefferies Global Healthcare Conference in London Format: Presentation and one-on-one meetingsPresenters: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge and Jeffrey Nau, PhD, MMS, President and Chief Executive Officer, VisaraDate: Monday, November 16, 2026Time: 5:30 AM ET \/ 10:30 &hellip; Continue reading &quot;NovaBridge Biosciences to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T12:36:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NovaBridge Biosciences to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-11-09T12:36:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":356,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"NovaBridge Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==\",\"datePublished\":\"2026-11-09T12:36:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NovaBridge Biosciences to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NovaBridge Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"NovaBridge Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"ROCKVILLE, Md., Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (\u201cNovaBridge\u201d or the \u201cCompany\u201d) (Nasdaq: NBP) today announced that members of its leadership team will participate in two upcoming investor conferences. At Jefferies, Chief Executive Officer Srishti Gupta will present with Jeffrey Nau, President and Chief Executive Officer of Visara, NovaBridge\u2019s majority-owned ophthalmology company focused on advancing a portfolio of differentiated therapies for ocular diseases. At Evercore, Dr. Gupta will be joined by NovaBridge Chief Financial Officer Chuck Silberstein. Conference details: Jefferies Global Healthcare Conference in London Format: Presentation and one-on-one meetingsPresenters: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge and Jeffrey Nau, PhD, MMS, President and Chief Executive Officer, VisaraDate: Monday, November 16, 2026Time: 5:30 AM ET \/ 10:30 &hellip; Continue reading \"NovaBridge Biosciences to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-09T12:36:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NovaBridge Biosciences to Participate in Upcoming Investor Conferences","datePublished":"2026-11-09T12:36:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/"},"wordCount":356,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/","name":"NovaBridge Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==","datePublished":"2026-11-09T12:36:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjU2MSM3OTUxOTE2IzUwMDEyNTAyOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NovaBridge Biosciences to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1018650"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018650\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1018650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1018650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1018650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}